Increased consumption of fish-derived n-3 long chain polyunsaturated fatty acids (n-3 PUFA) eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), as originally described in Inuit populations (Bang et al.,
1980), seems to be beneficial in the management of many inflammatory conditions (Calder, 2006a) including heart
disease (Lemaitre et al., 2003). Recommendations for intake have been issued for different populations including
athletes, who are advised to consume 1–2 g per day of n-3 PUFAs at a ratio of 2:1 for EPA:DHA (Simopoulos,
2007), although the evidence for this recommendation is not clear
Increased consumption of fish-derived n-3 long chain polyunsaturated fatty acids (n-3 PUFA) eicosapentaenoicacid (EPA) and docosahexaenoic acid (DHA), as originally described in Inuit populations (Bang et al.,1980), seems to be beneficial in the management of many inflammatory conditions (Calder, 2006a) including heartdisease (Lemaitre et al., 2003). Recommendations for intake have been issued for different populations includingathletes, who are advised to consume 1–2 g per day of n-3 PUFAs at a ratio of 2:1 for EPA:DHA (Simopoulos,2007), although the evidence for this recommendation is not clear
การแปล กรุณารอสักครู่..